lifibrol   Click here for help

GtoPdb Ligand ID: 5885

Synonyms: K 12148 | K12.148 | U-83860
Compound class: Synthetic organic
Comment: Lifibrol is a model compound being investigated in the development of novel pharmacotherapies for dyslipidaemia [1]. The compoound appears to be a cholesterol synthesis inhibitor.
The INN document for lifibrol specifies that it is a racemic mixture of two enatiomers. We do not specify stereochemistry in our structure therefore this entry represents the mixture.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 8
Topological polar surface area 66.76
Molecular weight 342.18
XLogP 4.92
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(COc1ccc(cc1)C(=O)O)CCc1ccc(cc1)C(C)(C)C
Isomeric SMILES OC(COc1ccc(cc1)C(=O)O)CCc1ccc(cc1)C(C)(C)C
InChI InChI=1S/C21H26O4/c1-21(2,3)17-9-4-15(5-10-17)6-11-18(22)14-25-19-12-7-16(8-13-19)20(23)24/h4-5,7-10,12-13,18,22H,6,11,14H2,1-3H3,(H,23,24)
InChI Key LNXBEIZREVRNTF-UHFFFAOYSA-N
References
1. Berthold HK, Sudhop T, von Bergmann K, Gouni-Berthold I. (2010)
Lifibrol as a model compound for a novel lipid-lowering mechanism of action.
J Cardiovasc Pharmacol Ther, 15 (4): 364-72. [PMID:20693157]
2. Locker PK, Jungbluth GL, Francom SF, Hughes Jr GS. (1995)
Lifibrol: a novel lipid-lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group.
Clin Pharmacol Ther, 57 (1): 73-88. [PMID:7828385]